Table 1 Pre- and post- treatment characteristics and pathologic outcomes of men undergoing radical prostatectomy at University of Pennsylvania, 1990–2012

iPSA (ng/ml)

0.95^b

 median

5.1

5.4

5.2

 mean

6.59

6.73

6.76

 IQR

3.9–6.8

4.2–7.2

4.1–7.2

Age (years)

0.37^b

 median

60

60

59

 mean

59.1

59.2

58.6

 IQR

54–64

54–64

54–63

Biopsy Gleason Score

0.46^a

  ≤ 6

150

82

459

76

293

77

 7

25

14

102

17

61

16

 8 to 10

7

4

40

7

73

6

Clinical T-stage

0.99^a

 T1c

121

80

392

81

251

80

 T2a

24

16

73

15

51

16

 T2b

3

2

9

2

6

2

 T2c

3

2

12

2

5

2

Race

<0.001 ^a

 white

149

83

487

82

270

71

 African-American/Black

31

17

106

18

112

29

 other

4

2

9

2

2

0.5

Pathologic Gleason Score

0.001 ^a

  ≤ 6

106

58

321

53

165

43

 7

71

39

252

42

186

48

 8 to 10

7

4

29

5

33

9

Nodal Status

0.47^a

 pN0

184

100

592

99

379

99

 pN1

0

0

3

1

3

1

Extraprostatic spread

39

21

130

22

117

30

0.004 ^a

Seminal Vesicle invasion

9

5

29

5

26

7

0.39^a

Positive surgical margin

19

10

108

18

78

21

0.01 ^a

Additional Radiotherapy

1

0.6

11

2

8

2

0.39^a

Hormonal Therapy

7

4

30

5

16

4

0.51^a

No. of patients

184

602

384